Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:07 pm Sale | 13G | ATYR PHARMA INC LIFE | Venrock Healthcare Capital Partners II L.P. | 1,171,436 4% | -393,564 (-25.15%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | SAVARA INC SVRA | Venrock Healthcare Capital Partners II L.P. | 6,351,531 5.6% | 164,249 (+2.65%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners II L.P. | 2,171,125 9.99% | 513,392 (+30.97%) | View |
| 2022-11-14 4:11 pm Purchase | 13G | SAVARA INC SVRA | Venrock Healthcare Capital Partners II L.P. | 6,187,282 5.4% | 6,187,282 (New Position) | View |
| 2022-10-28 4:05 pm Sale | 13G | TRICIDA INC TCDA | Venrock Healthcare Capital Partners II L.P. | 2,982,528 5.4% | -5,899,349 (-66.42%) | View |
| 2022-09-28 9:20 pm Purchase | 13G | TRICIDA INC TCDA | Venrock Healthcare Capital Partners II L.P. | 8,881,877 16% | 3,016,717 (+51.43%) | View |
| 2022-07-08 4:05 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II L.P. | 20,697,286 10% | 4,650,000 (+28.98%) | View |
| 2022-06-23 4:05 pm Purchase | 13G | ANNEXON INC ANNX | Venrock Healthcare Capital Partners II L.P. | 1,928,477 5% | 1,928,477 (New Position) | View |
| 2022-06-23 06:02 am Purchase | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Venrock Healthcare Capital Partners II L.P. | 9,402,828 9.9% | 9,402,828 (New Position) | View |
| 2022-06-06 5:31 pm Purchase | 13G | TRICIDA INC TCDA | Venrock Healthcare Capital Partners II L.P. | 5,865,160 10.6% | 2,370,309 (+67.82%) | View |
| 2022-05-27 4:05 pm Purchase | 13G | GH RESH PLC SHS GHRS | Venrock Healthcare Capital Partners II L.P. | 2,820,501 5.4% | 2,820,501 (New Position) | View |
| 2022-05-25 5:23 pm Purchase | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners II L.P. | 1,657,733 9.99% | 1,657,733 (New Position) | View |
| 2022-05-23 4:30 pm Purchase | 13G | AKOUOS INC AKUS | Venrock Healthcare Capital Partners II L.P. | 2,391,545 6.9% | 2,391,545 (New Position) | View |
| 2022-04-29 4:05 pm Purchase | 13G | INOZYME PHARMA INC INZY | Venrock Healthcare Capital Partners II L.P. | 4,065,000 9.8% | 4,065,000 (New Position) | View |
| 2022-04-22 4:05 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | Venrock Healthcare Capital Partners II L.P. | 3,433,050 9.999% | 3,433,050 (New Position) | View |
| 2022-04-21 4:05 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Venrock Healthcare Capital Partners II L.P. | 3,668,334 9.99% | 3,668,334 (New Position) | View |
| 2022-02-14 4:21 pm Sale | 13G | SIERRA ONCOLOGY INC SRRA | Venrock Healthcare Capital Partners II L.P. | 984,746 6.1% | -7,304,732 (-88.12%) | View |
| 2022-02-14 4:20 pm Sale | 13G | ALTIMMUNE INC ALT | Venrock Healthcare Capital Partners II L.P. | 1,760,870 4.2% | -1,862,094 (-51.40%) | View |
| 2022-02-14 4:20 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II L.P. | 16,047,286 8% | 1,807,049 (+12.69%) | View |
| 2022-02-14 4:19 pm Purchase | 13G | TRICIDA INC TCDA | Venrock Healthcare Capital Partners II L.P. | 3,494,851 6.3% | 3,494,851 (New Position) | View |